{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:25:17Z","timestamp":1770510317186,"version":"3.49.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/aci.0b013e32833bc0ba","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T07:51:51Z","timestamp":1278489111000},"page":"337-341","source":"Crossref","is-referenced-by-count":35,"title":["Long-term outcome after venom immunotherapy"],"prefix":"10.1097","volume":"10","author":[{"given":"David BK","family":"Golden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM197807272990401","article-title":"A controlled trial of immunotherapy in insect hypersensitivity","volume":"299","author":"Hunt","year":"1978","journal-title":"N Engl J Med"},{"key":"R2-13-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1398-9995.1979.tb02006.x","article-title":"Immunotherapy in bee sting hypersensitivity: bee venom versus whole body extract","volume":"34","author":"Muller","year":"1979","journal-title":"Allergy"},{"key":"R3-13-20210128","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0091-6749(85)90103-4","article-title":"Stinging insect allergy: natural history and modification with venom immunotherapy","volume":"75","author":"Reisman","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"R4-13-20210128","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1398-9995.2005.00960.x","article-title":"Prevention and treatment of Hymenoptea venom allergy: guidelines for clinical practice","volume":"60","author":"Bonifazi","year":"2005","journal-title":"Allergy"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaci.2005.01.005","article-title":"Insect sting allergy and venom immunotherapy: a model and a mystery","volume":"115","author":"Golden","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jaci.2004.07.046","article-title":"Stinging insect hypersensitivity: a practice parameter update","volume":"114","author":"Moffitt","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0091-6749(96)70302-0","article-title":"Discontinuing venom immunotherapy: outcome after five years","volume":"97","author":"Golden","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0091-6749(98)70239-8","article-title":"Discontinuing venom immunotherapy: extended observations","volume":"101","author":"Golden","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0091-6749(00)90092-7","article-title":"Survey of patients after discontinuing venom immunotherapy","volume":"105","author":"Golden","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.all.0000136755.13077.b5","article-title":"Diagnostic methods for insect sting allergy","volume":"4","author":"Hamilton","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI2250","article-title":"Role of interleukin 10 in specific immunotherapy","volume":"102","author":"Akdis","year":"1998","journal-title":"J Clin Invest"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.all.0000173784.81024.7a","article-title":"Are regulatory T cells the target of venom immunotherapy?","volume":"5","author":"Jutel","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2222.2006.02487.x","article-title":"Ultra-rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy","volume":"36","author":"Mamessier","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2222.2007.02887.x","article-title":"Expansion of circulating Foxp3+CD25brightCD+ T cells during specific venom immunotherapy","volume":"38","author":"Pereira-Santos","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaci.2008.09.023","article-title":"Serum cytotoxic T lymphocyte-associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy","volume":"123","author":"Saverino","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0091-6749(86)90177-6","article-title":"Clinical and immunologic observations in patients who stop venom immunotherapy","volume":"77","author":"Golden","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0091-6749(05)80019-3","article-title":"Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy","volume":"90","author":"Golden","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2222.2009.03436.x","article-title":"Serum concentration of baseline serum mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy","volume":"40","author":"Dugas-Breit","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1365-2222.2009.03303.x","article-title":"Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children","volume":"39","author":"Varga","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0091-6749(86)90379-9","article-title":"Evaluation of decline in serum venom-specific IgE as a criterion for stopping venom immunotherapy","volume":"77","author":"Randolph","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0091-6749(89)90446-6","article-title":"Further observations of stopping venom immunotherapy: comparison of patients stopped because of a fall in serum venom-specific IgE to insignificant levels with patients stopped prematurely by self-choice","volume":"83","author":"Reisman","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"R22-13-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-3476(85)80508-4","article-title":"Discontinuation of bee venom immunotherapy in children and adolescents","volume":"107","author":"Urbanek","year":"1985","journal-title":"J Pediatr"},{"key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0091-6749(93)90060-S","article-title":"Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis","volume":"92","author":"Reisman","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"R24-13-20210128","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0091-6749(98)70167-8","article-title":"Long-term protection after stopping venom immunotherapy","volume":"101","author":"Lerch","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R25-13-20210128","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-6749(91)90095-6","article-title":"Clinical and immunologic follow-up of patients who stop venom immunotherapy","volume":"88","author":"Keating","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"R26-13-20210128","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","article-title":"Elevated basal serum tryptase and Hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy","volume":"33","author":"Haeberli","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"R28-13-20210128","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase: a study of the EAACI Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R29-13-20210128","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1398-9995.2005.00894.x","article-title":"High sensitivity of basophils predicts side effects in venom immunotherapy","volume":"60","author":"Kosnik","year":"2005","journal-title":"Allergy"},{"key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1398-9995.2009.02118.x","article-title":"Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy","volume":"64","author":"Niedoszytko","year":"2009","journal-title":"Allergy"},{"key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"R32-13-20210128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaci.2007.11.010","article-title":"Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis","volume":"121","author":"DeOlano","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"R33-13-20210128","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0091-6749(92)90319-W","article-title":"Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety","volume":"89","author":"Muller","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"R34-13-20210128","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0091-6749(89)90320-5","article-title":"Prospective observations on patients who discontinue venom immunotherapy","volume":"84","author":"Golden","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"R35-13-20210128","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0091-6749(91)90392-2","article-title":"Honeybee venom allergy: results of a sting challenge 1 year after stopping venom immunotherapy in 86 patients","volume":"87","author":"Muller","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"R36-13-20210128","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1067\/mai.2001.119154","article-title":"Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses","volume":"108","author":"Rueff","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"R37-13-20210128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1081-1206(10)61689-4","article-title":"Rush venom immunotherapy in patients experiencing recurrent systemic reactions to conventional venom immunotherapy","volume":"91","author":"Goldberg","year":"2003","journal-title":"Ann Allergy"},{"key":"R38-13-20210128","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1067\/mai.2002.129124","article-title":"Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients","volume":"110","author":"Sturm","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"R39-13-20210128","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1081-1206(10)61088-5","article-title":"Ultrarush venom desensitization after systemic reactions during conventional venom immunotherapy","volume":"97","author":"Oren","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R40-13-20210128","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0091-6749(91)90391-Z","article-title":"In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy","volume":"87","author":"Haugaard","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"R41-13-20210128","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0091-6749(97)70271-9","article-title":"Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge","volume":"100","author":"VanHalteren","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"R42-13-20210128","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa022952","article-title":"Outcomes of allergy to insect stings in children with and without venom immunotherapy","volume":"351","author":"Golden","year":"2004","journal-title":"N Engl J Med"},{"key":"R43-13-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/ACI.0b013e328259c328","article-title":"Cardiovascular disease and anaphylaxis","volume":"7","author":"Muller","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R44-13-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0091-6749(97)70314-2","article-title":"Fatal anaphylaxis after a yellow jacket sting despite venom immunotherapy in two patients with mastocytosis","volume":"99","author":"Oude-Elberink","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"R45-13-20210128","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000113520","article-title":"Fatal anaphylactic sting reaction in a patient with mastocytosis","volume":"148","author":"Wagner","year":"2008","journal-title":"Int Arch Allergy Appl Immunol"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0b013e32833bc0ba","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T03:40:11Z","timestamp":1711597211000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201008000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e32833bc0ba","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}